Laregab NT 400mg/10mg Tablet is a combination pharmaceutical formulation containing Gabapentin 400mg and Nortriptyline 10mg, designed for the management of neuropathic pain and certain neurological disorders. Gabapentin, an anticonvulsant agent, modulates the release of excitatory neurotransmitters by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, thereby reducing neuronal hyperexcitability. Nortriptyline, a tricyclic antidepressant, exerts analgesic effects through inhibition of norepinephrine and serotonin reuptake, enhancing descending inhibitory pain pathways. The synergistic action of these agents provides effective relief from chronic neuropathic pain conditions such as diabetic neuropathy, postherpetic neuralgia, and other peripheral neuropathies. Laregab NT is typically administered orally once or twice daily, with dosing individualized based on clinical response and tolerability. Common adverse effects may include dizziness, somnolence, dry mouth, and gastrointestinal disturbances. Caution is advised in patients with a history of cardiac arrhythmias, glaucoma, or renal impairment. This combination therapy should be used under strict medical supervision, with periodic monitoring to assess efficacy and adverse reactions. Laregab NT offers a comprehensive approach to neuropathic pain management, improving patient quality of life through multimodal pharmacotherapy.